gemcitabine has been researched along with Thrombocythemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, S; Burgess, P; Doerfel, S; Forget, F; Kalambakas, S; Karaszewska, B; Khan, D; Mostafa Kamel, Y; Safran, H; Winer, ES | 1 |
| Aiba, K; Fujiwara, Y; Furukawa, K; Futagawa, Y; Kitamura, H; Misawa, T; Shiba, H; Tsutsui, N; Uwagawa, T; Yanaga, K | 1 |
| Abbate, MI; Agustoni, F; Bianchini, G; Bidoli, P; Canova, S; Cicchiello, F; Cortinovis, DL | 1 |
| Ahmed, S; Bhatt, H; Lee-Ying, R; Lim, J; Shahid, RK | 1 |
| Botta, M; Bretti, S; Castagneto, B; Dongiovanni, D; Muzio, A; Numico, G; Sinaccio, G; Zai, S | 1 |
| Kocijancic, I; Kovac, V; Segedin, B; Smrdel, U; Vrankar, M; Zwitter, M | 1 |
| Centoni, PE; Ceretelli, S; Liumbruno, G; Sodini, ML | 1 |
| Cufer, T; Wein, W; Zwitter, M | 1 |
4 trial(s) available for gemcitabine and Thrombocythemia
| Article | Year |
|---|---|
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.
Topics: Adult; Aged; Aged, 80 and over; Benzoates; Deoxycytidine; Female; Gemcitabine; Humans; Hydrazines; Male; Middle Aged; Neoplasms; Pyrazoles; Thrombocytosis | 2017 |
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Survival Analysis; Thrombocytosis; Treatment Outcome | 2005 |
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Heart Ventricles; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Thrombocytosis | 2005 |
Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Thrombocytosis; Treatment Outcome; Vincristine | 2001 |
4 other study(ies) available for gemcitabine and Thrombocythemia
| Article | Year |
|---|---|
Erlotinib-induced thrombocytosis in patients with recurrence of pancreatic cancer after distal pancreatectomy.
Topics: Chemotherapy, Adjuvant; Deoxycytidine; Erlotinib Hydrochloride; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatectomy; Pancreatic Neoplasms; Platelet Count; Quinazolines; Splenectomy; Thrombocytosis | 2013 |
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: analysis of 318 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Thrombocytosis; Treatment Outcome | 2017 |
Chemotherapy-related thrombocytosis: does it increase the risk of thromboembolism?.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Platelet Count; Risk Factors; Thrombocytosis; Thromboembolism | 2012 |
Rapid reduction of platelet numbers in thrombocytosis.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Male; Platelet Count; Plateletpheresis; Thrombocytosis; Time Factors | 2000 |